{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"370"},{"groupId":"OG002","value":"380"},{"groupId":"OG003","value":"538"},{"groupId":"OG004","value":"29"},{"groupId":"OG005","value":"105"},{"groupId":"OG006","value":"100"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"380"},{"groupId":"OG002","value":"382"},{"groupId":"OG003","value":"571"},{"groupId":"OG004","value":"36"},{"groupId":"OG005","value":"153"},{"groupId":"OG006","value":"152"}],"units":"Participants"}],"description":"Number of participants with complete response and very good partial response at the end of protocol therapy.","groups":[{"description":"All patients-off therapy before callback-Induction only","id":"OG000","title":"Arm I (Patients Off-therapy Before Callback-Induction Only)"},{"description":"RER with Complete Response - IFRT (Standard Arm)","id":"OG001","title":"Arm II (RER With CR [ABVE-PC, IFRT])"},{"description":"RER with Complete Response - no IFRT ( Reduced Therapy Arm)","id":"OG002","title":"Arm III (RER With CR [ABVE-PC])"},{"description":"RER with less than Complete Response - IFRT","id":"OG003","title":"Arm IV (RER With Less Than CR [ABVE-PC, IFRT])"},{"description":"RER with Progressive Disease - Off Therapy","id":"OG004","title":"Arm V (RER With PD)"},{"description":"SER - randomized to DECAX2 + ABVE-PCX2 + IFRT","id":"OG005","title":"Arm VI (SER [DECA, ABVE-PC, IFRT])"},{"description":"SER - randomized to ABVE-PCX2 + IFRT","id":"OG006","title":"Arm VII (SER [ABVE-PC, IFRT])"}],"paramType":"NUMBER","populationDescription":"Eligible participants are analyzed and ineligible participants (n=22) are excluded from Arms I (n=14), II (n=1), III (n=0), IV (n=6), V (n=0), VI (n=1), and VII (n=0).","reportingStatus":"POSTED","timeFrame":"Protocol therapy: the overall duration of which is: (n=1527) an average of 137.1 days, median 133.0 days, interquartile range: 101.0, 164.0 days.","title":"Disease Response Assessed by Modified RECIST Criteria","type":"SECONDARY","unitOfMeasure":"Number of participants"}